Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 26 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 10238710

    Peptide having anti-inflammatory, osteogenic and hair growth promoting activities, and use of same

    CAREGEN CO., LTD. · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  2. US 10233244

    Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  3. US 10232042

    Conjugates of an anti-TNF-alpha antibody

    Nektar Therapeutics · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  4. US 10227362

    Anti-pulmonary tuberculosis nitroimidazole derivative

    Medshine Discovery Inc. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  5. US 10221244

    Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer

    Five Prime Therapeutics, Inc. · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  6. US 10214522

    Anti-alphavbeta1 integrin inhibitors and methods of use

    The Regents of the University of California · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  7. US 10206897

    Creatine ester anti-inflammatory compounds and formulations

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  8. US 10207993

    Compounds as anti-tubercular agents

    DRUG DISCOVERY RESEARCH CENTRE · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  9. US 10202397

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

  10. US 10196450

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  11. US 10196458

    Anti-immunoglobulin E antibodies and methods of using thereof

    The Regents of the University of California · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  12. CA 3070264

    ASSOCIATIONS PHARMACEUTIQUES COMPRENANT UN ANTICORPS ANTI-BST-1 ET UN ANALOGUE DE CYTIDINE

    BERLIN CHEMIE AG [DE] · Granted Jan 24, 2019 · Expires Jan 19, 2039

    granted

  13. US 10183011

    Anti-depression compounds

    The Board of Regents of the University of Texas System · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  14. US 10182984

    Targeted interferons demonstrate potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  15. US 10179819

    Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  16. US 10179817

    Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  17. US 10174098

    Anti-human papillomavirus 16 E7 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  18. US 10172937

    Method of treatment of malignant solid tumors with afucosylated anti-FGFR2IIIb antibodies

    Five Prime Therapeutics, Inc. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  19. US 10167334

    Treatment of cancer using anti-TGF-BETA and PD-1 antibodies

    The Regents of the University of California · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  20. US 10160802

    Anti-malarial compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted

  21. US 10155798

    Anti-obesity compounds derived from neuromedin U

    The Regents of the University of California · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  22. US 10144767

    Anti-microbial peptides and coatings

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  23. US 10143724

    Anti-SSX-2 T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2018 · Expires Nov 29, 2038

    granted

  24. US 10138298

    Anti-IL-2 antibodies and compositions and uses thereof

    The Regents of the University of California · Granted Nov 27, 2018 · Expires Nov 22, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.